![]() |
市場調査レポート
商品コード
1386331
冠状動脈性心疾患画像診断装置市場レポート:2030年までの動向、予測、競合分析Coronary Heart Disease Diagnostic Imaging Devices Market Report: Trends, Forecast and Competitive Analysis to 2030 |
||||||
カスタマイズ可能
適宜更新あり
|
冠状動脈性心疾患画像診断装置市場レポート:2030年までの動向、予測、競合分析 |
出版日: 2023年10月03日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
|
世界の冠状動脈性心疾患画像診断装置市場は、2024年から2030年までのCAGRが6.2%で、2030年までに推定21億米ドルに達すると予測されます。この市場の主な促進要因は、冠動脈疾患の有病率の増加、早期診断技術の採用の増加、非侵襲的診断技術に対するニーズの高まりです。コンピューター断層撮影、X線、超音波、磁気共鳴画像、核医学の各市場における機会により、世界の冠状動脈性心疾患画像診断装置市場の将来は有望です。
Lucintelは、核医学は非侵襲性、画像の鮮明さ、初期段階での疾患の正確な検出により、予測期間中最大のセグメントであり続けると予測しています。
北米は、技術的に優れた医療スタッフの存在、政府によるヘルスケア支出の改善、同地域でのがん患者数の増加により、予測期間中も最大セグメントであり続けると思われます。
The future of the global coronary heart disease diagnostic imaging devices market looks promising with opportunities in the computed tomography, x ray, ultrasound,magnetic resonance imaging, and nuclear medicine markets. The global coronary heart disease diagnostic imaging devices market is expected to reach an estimated $2.1 billion by 2030 with a CAGR of 6.2% from 2024 to 2030. The major drivers for this market are growing prevalence of coronary artery diseases, increasing adoption of early diagnostic techniques, and the rising need for non-invasive diagnostic techniques.
A more than 150-page report is developed to help in your business decisions.
The study includes a forecast for the global coronary heart disease diagnostic imaging devices by modality and region.
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies coronary heart disease diagnostic imaging devices companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the coronary heart disease diagnostic imaging devices companies profiled in this report include-
Lucintel forecasts that nuclear medicine will remain the largest segment over the forecast period owing to its non-invasiveness, clarity of image, and accurate detection of disease even at a nascent stage.
North America will remain the largest segment over the forecast period due to the existence of technologically sound medical staff, improved healthcare expenditure by the government, and increasing number of cancer cases in the region.
Market Size Estimates: Coronary heart disease diagnostic imaging devices market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Coronary heart disease diagnostic imaging devices market size by modality and region in terms of value ($B).
Regional Analysis: Coronary heart disease diagnostic imaging devices market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different modalities and regions for the coronary heart disease diagnostic imaging devices market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the coronary heart disease diagnostic imaging devices market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Answer: The global coronary heart disease diagnostic imaging devices market is expected to reach an estimated $2.1 billion by 2030.
Answer: The global coronary heart disease diagnostic imaging devices market is expected to grow with a CAGR of 6.2% from 2024 to 2030.
Answer: The major drivers for this market are growing prevalence of coronary artery diseases, increasing adoption of early diagnostic techniques, and the rising need for non-invasive diagnostic techniques.
Answer: The future of the coronary heart disease diagnostic imaging devices market looks promising with opportunities in the computed tomography, x ray, ultrasound,magnetic resonance imaging, and nuclear medicine markets.
Answer: Some of the key coronary heart disease diagnostic imaging devices companies are as follows:
Answer: Lucintel forecasts that nuclear medicine will remain the largest segment over the forecast period owing to its non-invasiveness, clarity of image, and accurate detection of disease even at a nascent stage.
Answer: North America will remain the largest segment over the forecast period due to the existence of technologically sound medical staff, improved healthcare expenditure by the government, and increasing number of cancer cases in the region.
Answer: Yes, Lucintel provides 10% customization without any additional cost.